Censo develops induced pluripotent stem cells to the pharmaceutical and drug discovery companies... Read more
Censo Biotechnologies CEO: Aidan Courtney

CEO

Aidan Courtney

CEO Approval Rating

70/100

2016

PrivateMerger Pending with Axol Bioscience Ltd.

Est. Annual Revenue
<$1M
Agree?
Est. Employees
<10
Agree?
Funding
$1.7M

Trending Companies